Press Releases

In response to the growing demand for high-quality, scalable lentiviral vectors crucial in advancing innovative gene therapies, Wacker Biotech US Inc., a wholly owned subsidiary of Wacker Chemie AG specializing in plasmid DNA (pDNA) production, and Expression Manufacturing, a leader in viral vector technology, have entered into a strategic collaboration.

WACKER customers now have access to comparable sustainability data for the company’s products.

WACKER is responding to rising demand for high-quality specialty silicones in China by expanding its production capacities at its Zhangjiagang site.

BENEO, a leading manufacturer of functional ingredients for food, feed and pharma, and WACKER, a European expert in biotechnology solutions for the food and pharma industry, are launching the human milk oligosaccharide (HMO) 2’-Fucosyllactose (2’-FL) globally.

Chemicals group WACKER has commenced production of hybrid polymers at its Nünchritz site.